|
⚲
|
| Keyboard |
| Nantahala Capital Management LLC | |
|---|---|
| Firm | |
| Address | 130 Main Street 2nd Floor New Canaan, CT 06840 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| NCP RFF LP | 021-376967 | Promoter | 75.0 M | ||
| Nantahala Capital Offshore Fund Ltd | 021-149696 | Promoter | 328.6 M | ||
| Nantahala Capital Partners Limited Partnership | 021-149331 | Promoter | 185.5 M | ||
| Nantahala Capital Management LLC | |||||
| NCP QR LP | 021-336387 | Executive Officer | 76.6 M | 69.1 M | |
| Nantahala Capital Partners SI LP | 021-240432 | Executive Officer | 513.6 M | 81.0 M | |
| Nantahala Capital Partners II Limited Partnership | 021-149697 | Promoter | 490.9 M | 53.1 M | |
| Nantahala Capital Partners Limited Partnership | 021-178760 | Promoter | 38.5 M | 914.6 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Talphera Inc TLPH
Pre-Funded Warrants · derivative
|
2026-03-13 | Grant | 4,266,211 | $0.59 | 2,517,064 |
|
Evoke Pharma Inc EVOK
Prefunded Warrants · derivative
|
2025-12-17 | Other | 433,962 | $11.00 | 4,773,582 |
|
Evoke Pharma Inc EVOK
Series A Common Stock Purchase Warrants · derivative
|
2025-12-17 | Other | 117,019 | $4.71 | 551,159 |
|
Evoke Pharma Inc EVOK
Common Stock
|
2025-12-17 | Other | 148,153 | $11.00 | 1,629,683 |
|
Evoke Pharma Inc EVOK
Amended Series C Common Stock Purchase Warrants · derivative
|
2025-12-17 | Other | 250,627 | $10.99 | 2,754,391 |
|
Evoke Pharma Inc EVOK
Amended Series A Common Stock Purchase Warrants · derivative
|
2025-12-17 | Other | 158,531 | $10.99 | 1,742,256 |
|
Evoke Pharma Inc EVOK
Series C Common Stock Purchase Warrants · derivative
|
2025-12-17 | Other | 117,019 | $4.71 | 551,159 |
|
Aytu Biopharma Inc AYTU
Prefunded Warrants · derivative
|
2025-06-06 | Buy | 4,000,000 | $1.50 | 6,000,000 |
|
Talphera Inc TLPH
Pre-Funded Warrants · derivative
|
2025-03-31 | Grant | 4,266,211 | $0.59 | 2,517,064 |
|
Evoke Pharma Inc EVOK
Common Stock
|
2025-01-28 | Sell | 41 | $4.39 | 180 |
|
Aytu Biopharma Inc AYTU
Exchange Warrants · derivative
|
2024-06-14 | Option exercise | 815,217 | $0.00 | |
|
Aytu Biopharma Inc AYTU
Tranche B Warrant · derivative
|
2024-06-14 | Option exercise | 815,217 | $0.00 | |
|
Talphera Inc TLPH
2024 Pre-Funded Warrants · derivative
|
2024-03-19 | Other | 324,675 | ||
|
Talphera Inc TLPH
Common Stock
|
2024-03-15 | Option exercise | 755,000 | $5.00 | 3,775,000 |
|
Talphera Inc TLPH
Put Option (obligation to buy) · derivative
|
2024-03-15 | Option exercise | 755,000 | $0.00 | |
|
Talphera Inc TLPH
2023 Series B Warrants · derivative
|
2024-01-22 | Disposed to issuer | 2,205,883 | ||
|
Talphera Inc TLPH
2023 Series B Warrants · derivative
|
2024-01-22 | Grant | 2,205,883 | ||
|
Talphera Inc TLPH
2023 Series A Warrants · derivative
|
2024-01-22 | Grant | 2,205,883 | ||
|
Talphera Inc TLPH
2023 Series A Warrants · derivative
|
2024-01-22 | Disposed to issuer | 2,205,883 | ||
|
Talphera Inc TLPH
2024 Pre-Funded Warrants · derivative
|
2024-01-22 | Grant | 6,168,832 | $0.77 | 4,750,001 |
| showing 20 of 33 most recent transactions | |||||